Petros Pharmaceuticals, Inc.·4

Nov 30, 2:49 PM ET

SHULMAN JOHN D 4

4 · Petros Pharmaceuticals, Inc. · Filed Nov 30, 2021

Insider Transaction Report

Form 4
Period: 2021-11-29
SHULMAN JOHN D
Director10% Owner
Transactions
  • Purchase

    Warrant

    2021-11-29+375,000375,000 total(indirect: See Footnote)
    Exercise: $3.50From: 2021-12-02Exp: 2026-12-02Common Stock (375,000 underlying)
  • Purchase

    Common Stock, par value $0.0001 per share

    2021-11-29$3.00/sh+500,000$1,500,0005,557,771 total(indirect: See Footnote)
Footnotes (1)
  • [F1]See Note (1) in Exhibit 99.1.

Documents

3 files